Bradley Alford Offloads PRGO Shares
Bradley Alford sold 976 shares of PRGO on June 12, 2026.
Key Points
- Bradley Alford sold 976 shares of PRGO on June 12, 2026, as the stock traded around $10.70.
- PRGO shares have a market price near $10.70, with major institutional investors making notable changes in their holdings.
- Analysts from Canaccord Genuity and JP Morgan have maintained their ratings with targets of $17 and $18, respectively.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 12, 2026, Bradley Alford sold 976 shares of PRGO. The transaction wasn't planned, and the shares were sold under a transaction code 'M'. PRGO shares were trading around $10.70 at the time.
Other Institutional Activity in PRGO
Several major institutional investors have adjusted their holdings in PRGO. BlackRock, Inc. increased its stake by 526,661 shares, bringing its total to 17,120,084 shares valued at approximately $183.9 million. Neuberger Berman Group LLC also added 2,924,771 shares, ending with 10,460,080 shares worth about $112.3 million. On the other hand, Price T Rowe Associates Inc. reduced its holdings by 4,197,451 shares, resulting in 13,376,776 shares valued at $143.7 million. Vanguard Portfolio Management LLC holds 8,141,919 shares valued at $87.4 million after a significant increase.
Perrigo Company plc Stock Down 26.1%
PRGO shares currently trade near $10.70. The stock has seen various institutional investors adjust their positions recently, reflecting ongoing interest and activity in the market.
Insider Buying and Selling at Perrigo Company plc
On June 12, 2026, Bradley Alford sold 976 shares of PRGO, while Geoffrey Parker sold 469 shares at $10.99 per share. These transactions were not part of any pre-arranged trading plans.
Analysts Set New Price Targets
Analysts have been active in updating their views on PRGO. On February 27, 2026, Canaccord Genuity maintained a 'buy' rating with a price target of $17. JP Morgan has a 'hold' rating with an $18 target from December 15, 2025. Overall, analysts have mixed views on PRGO, with varying price targets.
About PRGO
PRGO, also known as Perrigo Company plc, is a global provider of over-the-counter health and wellness solutions. The company focuses on producing and distributing private-label products and branded consumer healthcare goods. Headquartered in Dublin, Ireland, PRGO serves markets worldwide with products ranging from pharmaceuticals to nutritional supplements.
Bottom Line
Bradley Alford's recent sale of PRGO shares highlights ongoing insider activity. Investors often keep an eye on such transactions for potential insights into company sentiment. Institutional investors have also made significant changes to their holdings, indicating a dynamic interest in PRGO. As always, 13F filings and insider reports provide a historical snapshot and may not reflect current positions.
Get Perrigo Company plc alerts
New 13F filings, insider trades, and analyst moves on $PRGO, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.